No Data
Aldeyra Therapeutics' Resubmitted Marketing Application for Eye Disease Drug Accepted by FDA
AbbVie Gets European OK of Elahere in Platinum-Resistant Ovarian Cancer
Wells Fargo Maintains AbbVie(ABBV.US) With Buy Rating, Cuts Target Price to $195
AbbVie Snaps Eight Straight Sessions of Losses
S&P Sees Some Signs of a US Credit Bubble as Spreads Tighten
Monday Market Slow but Steady, Trump Buying Crypto Firm | Wall Street Today
102171590 : imagine it crashes to 53